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Abstract Evolutionary theories of aging predict a
trade-off between fertility and lifespan, where in-
creased lifespan comes at the cost of reduced fertility.
Support for this prediction has been obtained from
various sources. However, which genes underlie this
relationship is unknown. To assess it, we first
analyzed the association of fertility with age at
menarche and menopause, and with mortality in
3,575 married female participants of the Rotterdam
Study. In addition, we conducted a candidate gene
study where 1,664 single nucleotide polymorphisms
(SNPs) in 25 candidate genes were analyzed in
r e l a t i o nt on u m b e ro fc h i l d r e na sam e a s u r eo f
fertility. SNPs that associated with fertility were
analyzed for association with mortality. We observed
no associations between fertility and age at menarche
(p=0.38) and menopause (p=0.07). In contrast,
fertility was associated with mortality. Women with
two to three children had significantly lower mortality
(hazard ratio (HR), 0.82; 95% confidence interval
(95% CI), 0.69–0.97) compared to women with no
children. No such benefit was observed for women
with four or more children, who had a similar
mortality risk (HR, 0.93; 95% CI, 0.76–1.13) as
women with no children. The analysis of candidate
genes revealed four genes that influence fertility after
correction for multiple testing: CGB/LHB gene cluster
(p=0.0036), FSHR (p=0.023), FST (p=0.023), and
INHBA (p=0.021). However, none of the independent
SNPs in these genes predicted mortality. In conclu-
sion, women who bear two to three children live
longer than those who bear none or many children,
but this relationship was not mediated by the
candidate genes analyzed in this study.
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Introduction
Evolutionary theories of aging predict a trade-off
between fertility and lifespan, where increased life-
span comes at the cost of reduced fertility (Kirkwood
1977; Williams 1957). Studies in model organisms
have provided evidence for this prediction (Rose and
Charlesworth 1980; Stearns and Partridge 2001). In
humans, however, no convincing support for this
hypothesis has been obtained when historical popula-
tions were studied. However, in contemporary pop-
ulations, a trade-off between fertility and lifespan has
been observed (Hurt et al. 2006; Le Bourg 2007). It is
likely that genes underlie this relationship but the
identity of these genes has largely remained unknown.
According to the antagonistic pleiotropy theory
(Williams 1957) and the disposable soma theory
(Kirkwood and Rose 1991; Kirkwood 1977) of aging,
a trade-off between reproduction and lifespan exists.
The disposable soma theory emphasizes energetic and
metabolic costs associated with reproduction, which
may lead to deterioration in maternal condition,
increase risk of disease, and lead to higher mortality.
The antagonistic pleiotropy theory, on the other hand,
emphasizes a genetic trade-off, where genes that
increase reproductive potential early in life increase
risk of disease and mortality later in life. Such a trade-
off would be expected even for women who have not
given birth but who carry these gene variants. Several
researchers have sought evidence for the trade-off
between fertility and lifespan, with elusive results. In
historical populations, negative (Korpelainen 2000;
Penn and Smith 2007; Westendorp and Kirkwood
1998), positive (Korpelainen 2000; Le Bourg 2007;
McArdle et al. 2006; Muller et al. 2002), and no
relationship (Helle et al. 2004; Lycett et al. 2000)
between fertility and lifespan have been reported. In
contemporary populations, however, the results are
more uniform. In several studies, it has been observed
thatwomenwithnochildrenandwomenwithmorethan
four children have the highest mortality (Doblhammer
2000;H u r te ta l .2006)
The increased mortality for women with no or with
many children suggests that either the same or
different genes are at play. To date, a number of
genes have been identified to influence female
fertility. In addition, it has been estimated that the
heritability of female lifetime reproductive success in
a contemporary population is 22% (Kosova et al.
2010) whereas in a preindustrial population, it was
estimated to reach 47% (Pettay et al. 2005). These
estimates reflect an underlying genetic architecture of
female fertility. According to the antagonistic pleiot-
ropy theory of aging, the same genes should influence
human lifespan.
Evidence suggests that age at menarche and
menopause also influence female fertility. It has been
found that women with earlier menarche have higher
fertility (Borgerhoff Mulder 1989), but not all studies
corroborate this finding (Helm et al. 1995; Sandler et
al. 1984). Likewise, later age at menopause has been
related to higher number of live births (Bromberger et
al. 1997; Parazzini et al. 1992; Stanford et al. 1987;
Whelan et al. 1990). In addition, later age at
menopause has been associated with increased risk
of breast and endometrial cancer, but with decreased
risk of osteoporosis and cardiovascular diseases (Hu
et al. 1999; Sowers and La Pietra 1995). These effects
have been attributed to high lifetime exposure to
estrogens. Given these associations, it is likely that
age at menarche and at menopause could predict
mortality at old age.
In this study, we set out to examine the relationship
between fertility and lifespan and explore the influ-
ences of age at menarche and menopause on these
phenotypes. In addition, we conducted a candidate
gene study in order to identify genes that could
influence both fertility and lifespan in an antagonistic
manner. We expected that genetic variants that
associate with increased fertility would result in
higher mortality. The study was carried out in married
female participants of the prospective Rotterdam
Study.
Methods
Study population
This study is embedded in the Rotterdam Study, an
ongoing population-based cohort on risk factors for
chronic diseases in the elderly. Detailed information
on design, objectives, and methods has been pre-
sented elsewhere (Hofman et al. 2009). For this study,
data from the first (RSI) and second (RSII) cohort of
616 AGE (2011) 33:615–622the Rotterdam Study were available. In RSI, all
inhabitants aged over 55 years living in the Ommoord
district of Rotterdam were invited to participate. Of
these 7,983 (78%) agreed to participate. In 1999,
3,011 participants (out of 4,472 invitees) who had
become 55 years of age or moved into the study
district since the start of the study were added to the
cohort (RSII). All participants of the Rotterdam Study
were followed for mortality until January 1, 2009.
The current study included 3,575 married female
participants of the Rotterdam Study. The Medical
Ethics Committee of the Erasmus Medical Center
approved the Rotterdam Study, and written informed
consent was obtained from all participants.
Fertility and age at menarche and at menopause
As a measure of fertility, data on self-reported number
of children were used. Women were asked, “How
many children do you have?” Fertility was analyzed
linearly but also categorically, where women were
categorized into the following groups: (1) childless
vs. with children and (2) no children, one child, two
to three children, and four or more children. Data on
age at menarche were collected by asking women,
“How old were you when you had your first
menstrual period?”, and data on age at menopause
were collected by asking women, “How old were you
when you had your last menstrual period?” Self-
reported age at menopause was defined as 12 months
after periods had ceased. The retrospective data on
self-reported number of children, age at menarche and
at menopause were collected by a questionnaire
during the first RSI interview (1990–1993) and during
the first RSII interview (1999–2001).
Confounders
The following variables were considered as possible
confounders: age at baseline, date of birth, smoking,
and socioeconomic status. Smoking status was de-
fined as having never smoked, being former or being
current smoker. To correct for differences in socio-
economic status, data on education and household
income were used. The participants were asked about
their formal education, the number of years in each
type of education, and whether education had been
completed. Based on these data, education was
divided into two levels: lower and higher education.
The lower education category included participants
with primary, lower vocational, and lower secondary
education. The high education category included
participants with intermediate vocational, general
secondary, higher vocational, and university educa-
tion. Household income was classified into 13 pre-
coded categories. Equivalent household income was
defined as the midpoint of each income category
divided by the number of persons living on that
income raised to the power 0.36 (Buhmann et al.
1988).
Candidate genes and genotype data
Altogether, 25 candidate genes were selected based
on their involvement in female fertility according to
the published literature (Supplementary table 1).
These genes function in hypothalamic–pituitary–ovar-
ian (HPO) axis, folliculogenesis, and implantation
processes. From these genes and within 10-kb vicinity
1,756 single nucleotide polymorphisms (SNPs) were
selected for study. Genotype data for these SNPs were
obtained from genome-wide genotyping data of the
Rotterdam Study. The genome-wide genotyping was
performed with Illumina 550K array (Illumina, San
Diego, CA, USA) in self-reported Caucasian individ-
uals (sample call rate, ≥97.5%). Individuals with
excess of autosomal heterozygosity, mismatch be-
tween genotypic and phenotypic gender, and outliers
identified by the identity-by-state clustering analysis
were excluded. This genotype data were used to
impute 2.5 million autosomal SNPs described in
HapMap’s Phase II European population panel with
the imputation software MACH (http://www.sph.
umich.edu/csg/abecasis/MACH). Such SNP imputa-
tion infers genotypes probabilistically according to
shared haplotype stretches between the study samples
and HapMap release 22 build 36 data. From the 1,756
SNPs in the candidate genes, 62 were excluded due to
a minor allele frequency (MAF) of less than 1% and
30 SNPs due to the Hardy–Weinberg equilibrium
p value lower than 1%, resulting in 1,664 SNPs for
further analyses.
Statistical analysis
First, we analyzed the association between fertility
and age at menarche and age at menopause with
linear regression. Second, we assessed the relation of
AGE (2011) 33:615–622 617fertility, age at menarche and at menopause with
mortality using Cox proportional hazard regression.
Third, the function- and gene-wide influence of SNPs
on fertility was determined with a set-based test,
implemented in PLINK (Purcell et al. 2007)( http://
pngu.mgh.harvard.edu/~purcell/plink/). The default
settings of PLINK were used (r
2=0.05; p value<
0.05; max number of SNPs, 5). The significance of
SNP combinations within a function or a gene was
estimated using 10,000 permutations. Where a func-
tion or a gene met a significance threshold of p<0.05
after permutations, independently associated SNPs
within these, as defined by PLINK, were analyzed
further for association with fertility and mortality.
Fourth, the association between SNPs and fertility
was assessed with logistic regression. Finally, the
association between SNPs and mortality was analyzed
with Cox proportional hazard regression. All analyses
were adjusted for birth year and education, except the
mortality analyses which were additionally adjusted
for age at baseline and education. All analyses were
repeated with additional adjustment for household
income and smoking status. Data were analyzed with
SPSS version 17 (SPSS Inc, Chicago, IL, USA) and
PLINK version 1.07 (Purcell et al. 2007) statistical
software.
Results
The characteristics of the 3,575 study participants are
presented in Table 1. All women were born between
1893 and 1944, and their mean age at baseline was
68 years. Of the 3,575 participants, 2,370 (67%) had a
lower education. The number of children in this
population ranged from 0 to 16 (mean (SD), 2.22
(1.53)). Women with no children (n=471) constituted
13% of the population. Data on mortality were
available for 3,238 participants. Of these participants,
1,116 (66%) died during a mean follow-up period of
12.1 years.
In this study, age at menarche and at menopause
had no pronounced influence on fertility, neither when
analyzed linearly nor when categorizing women based
on the number of children they have had (Table 2).
The only trend observed involved women with two or
three children who had later menopause compared to
women with no children (estimate standard error
(SE), 0.56 (0.29), p=0.06). This trend was also
reflected when fertility was analyzed by comparing
women who have had children with women with no
children (estimate (SE), 0.49 (0.28), p=0.07). In
contrast, mortality risks were not influenced by age
at menarche (hazard ratio (HR), 0.99; 95% confidence
interval (95% CI), 0.95–1.02) and at menopause (HR,
0.99; 95% CI, 0.98–1.00; Table 2).
Next, we assessed the association between fertility
and all-cause mortality. We observed no linear
relation between the number of children and mortality
(HR, 0.99; 95% CI, 0.95–1.02; Table 2). But, when
comparing women with two or three children with
women with no children, it became apparent that they
have significantly lower mortality (HR, 0.82; 95% CI,
0.69–0.97; Fig. 1). No such benefit was observed for
women with four or more children, who had a similar
mortality risk (HR, 0.93; 95% CI, 0.76–1.13) as
women with no children (Table 2), but a higher
mortality risk when compared to women with two to
three children (HR, 1.13; 95% CI, 0.96–1.32).
To explore the influence of genetic variation on
fertility, we first assessed the combined effect of SNPs
in folliculogenesis, HPO axis, and implantation on
fertility. From these three functions, the combined
effect of SNPs involved in HPO axis revealed a trend
for association with fertility after permutations (p=
0.09; Supplementary table 2). To determine which of
the 25 selected candidate genes contain SNPs that
influence fertility the most, we performed a gene-wide
association analysis. This approach revealed four genes
that influence fertility after permutations: CGB/LHB (0
vs. 2–3 children, p=0.0036), FSHR (0 vs. ≥4c h i l d r e n ,
p=0.023), FST (0 vs. ≥4c h i l d r e n ,p=0.023), and
Table 1 Characteristics of the study participants
Number 3,575
Age at baseline (mean, SD) 68 (9.49)
Low education (n, %) 2,370 (67%)
Age at menarche (mean, SD) 13.6 (1.78)
Age at menopause (mean, SD) 48.8 (5.31)
Fertility
0 children (n, %) 471 (13%)
1 child (n, %) 577 (16%)
2–3 children (n, %) 1,975 (55%)
≥4 children (n, %) 552 (16%)
Mortality (n, %) 1,116/3,238 (66%)
Follow-up (mean, SD) 12.1 (4.88)
618 AGE (2011) 33:615–622INHBA (0 vs. 1 child, p=0.021) (Supplementary
table 2). Independent SNPs from these four candidate
genes were further examined for their association with
fertility and mortality.
The CGB/LHB gene cluster contained three SNPs,
and FSHR contained five SNPs whereas FST and
INHBA both contained one independent SNP. For all
analyzed SNPs, a similar influence across the fertility
categories was observed (Table 3). For instance,
women carrying the rs1062708 SNP in CGB/LHB
gene cluster had a high probability to have one child
(OR, 1.20; 95% CI, 1.01–1.45), but lower probabilities
to have two to three (OR, 1.13; 95% CI, 0.97–1.31) or
four or more children (OR, 1.07; 95% CI, 0.89–1.27)
when compared to women with no children. Finally,
we tested the association of these SNPs with mortality.
Despite their association with fertility, none of these
SNPs directly predicted mortality (see also Table 3).
All reported analyses were repeated with additional
adjustment for household income and smoking status,
without leading to changes in results (data not
shown).
Discussion
In this study, we found that women with two or three
children have lower mortality compared to women
with no children. No such benefit was observed for
women with four or more children, who had a similar
mortality risk as women with no children. This
relationship between fertility and lifespan was not
mediated by the analyzed candidate genes. In addition,
we found no pronounced influence of age at menarche
and at menopause on fertility and lifespan.
The relationship between fertility and lifespan has
previously been studied by a number of studies.
Similar to other studies (Hurt et al. 2006), we found
no linear relationship between number of children and
lifespan. Instead, we observed that women with no
children and with four or more children had the
highest mortality. It has been hypothesized that with
repeated pregnancies, women become depleted of
resources that would otherwise be available for
maintenance and repair of the body, and hence, lead
to higher mortality (Kirkwood and Rose 1991;
Winkvist et al. 1992). In addition, it has been
suggested that repeated pregnancies result in perma-
nent detrimental effects on lipid and glucose metab-
olism (Martin et al. 1999; Sattar and Greer 2002) and
this way contribute to higher risk for coronary artery
disease, stroke, diabetes (Lawlor et al. 2003; Qureshi
Menarche
a Menopause
a Mortality
b
Estimate (SE) p value Estimate (SE) p value HR (95% CI)
Fertility
0 children Reference – Reference – Reference
1 child −0.18 (0.11) 0.10 0.31 (0.34) 0.37 0.96 (0.79–1.17)
2–3 children −0.11 (0.09) 0.25 0.56 (0.29) 0.06 0.82 (0.69–0.97)*
≥4 children 0.13 (0.11) 0.27 0.49 (0.35) 0.16 0.93 (0.76–1.13)
Fertile (yes/no) −0.08 (0.09) 0.38 0.49 (0.28) 0.07 0.87 (0.74–1.02)
Per child 0.02 (0.02) 0.21 0.10 (0.06) 0.09 0.99 (0.95–1.02)
Age at menarche –– –– 0.99 (0.95–1.02)
Age at menopause –– –– 0.99 (0.98–1.00)
Table 2 Association of fertil-
ity with age at menarche and
menopause,andwithmortality
The number of deaths during
follow-up in the different
fertility categories: 0 children
(n=189), one child (n=201),
2–3 children (n=512),
≥4c h i l d r e n( n=214)
*p<0.05
aEducation- and birth year-
adjusted linear regression
b Cox proportional hazard
model adjusted for education
and age at baseline
Fig. 1 Kaplan–Meier survival curves for women with different
numbers of children. The hazard ratio (HR) with 95%
confidence interval (CI) for the comparison of women with
no children and women with two to three children is adjusted
for age at baseline and education
AGE (2011) 33:615–622 619et al. 1997), and to higher mortality later in life. On
the other hand, the higher mortality among women
with no children has probably different biological
causes. It is likely that mechanisms that lead to
infertility have also detrimental effects on other
physiological processes, thereby contributing to
higher mortality.
Female reproductive lifespan is determined by the
onset and cessation of menstruation. It has been found
that both the age at menarche and at menopause
influence fertility (Borgerhoff Mulder 1989; Parazzini
et al. 1992; Stanford et al. 1987; Whelan et al. 1990).
In this study, we found no effects of age at menarche
on fertility. For age at menopause, in contrast, we
observed that women with children tended to have
their menopause at later ages than women without
children. Interestingly, it has been reported that
women who have their menopause at later ages have
decreased risk of having a heart attack, stroke, or
other cardiovascular disease event, but increased risk
of having breast or endometrial cancer (Hu et al.
1999; Sowers and La Pietra 1995). These associations
are in an opposite direction than the disease risks
associated with higher fertility, which highlight the
complex interactions between them. This might also
explain why no association between age at menopause
and mortality was observed in this study.
Over the years, a number of genes have been
identified to influence fertility. In this study, we
selected candidate genes that are involved in HPO
axis, folliculogenesis, and implantation process. From
these, three genes (CGB/LHB gene cluster, FSHR, and
INHBA) involved in HPO axis and one gene (FST)
involved in folliculogenesis were associated with
fertility. The CGB/LHB gene cluster is located in a
gene-rich region which is targeted by natural selection
and gene conversion events (Nagirnaja et al. 2010).
Given the association of the CGB/LHB gene cluster
with fertility and the fact that it is located in a region
under natural selection, an influence of genetic
variants in this gene cluster on lifespan would have
been expected. This, however, was not the case.
Likewise, an effect on mortality would have been
expected for the FSHR gene variants since SNPs in
FSHR have been associated with hypertension
(Nakayama et al. 2006), bone mineral density
Table 3 Influence of SNPs in candidate genes on fertility and mortality
Fertility Mortality
0 vs. 1 child 0 vs. 2–3 children 0 vs. ≥4 children
Gene MAF OR (95% CI) OR (95% CI) OR (95% CI) HR (95% CI)
CGB/LHB
rs753308 0.41 0.70 (0.59–0.86)** 0.78 (0.67–0.91)** 0.74 (0.62–0.89)** 1.01 (0.93–1.10)
rs3752210 0.41 0.70 (0.61–0.89)** 0.78 (0.67–0.90)** 0.74 (0.62–0.89)** 1.03 (0.94–1.11)
rs1062708 0.49 1.20 (1.01–1.45)* 1.13 (0.97–1.31) 1.07 (0.89–1.27) 1.02 (0.94–1.11)
FSHR
rs1277460 0.21 0.90 (0.70–1.07) 0.89 (0.75–1.06) 0.66 (0.52–0.83)** 0.95 (0.85–1.05)
rs6545094 0.42 1.20 (1.03–1.50)* 1.20 (1.03–1.40)* 1.35 (1.11–1.64)** 0.98 (0.90–1.06)
rs3913665 0.41 0.90 (0.71–1.02) 0.92 (0.79–1.07) 0.75 (0.62–0.91)** 1.03 (0.94–1.12)
rs971831 0.30 1.10 (0.90–1.34) 1.12 (0.95–1.32) 1.31 (1.06–1.60)* 1.00 (0.92–1.10)
rs2268360 0.22 0.90 (0.75–1.16) 0.90 (0.76–1.07) 0.76 (0.61–0.94)* 0.98 (0.89–1.08)
FST
rs10080213 0.24 1.30 (1.03–1.58)* 1.15 (0.96–1.38) 1.37 (1.10–1.70)** 1.01 (0.92–1.12)
INHBA
rs2237432 0.25 1.37 (1.10–1.71)** 1.24 (1.04–1.49)* 1.11 (0.89–1.38) 0.97 (0.88–1.07)
Association with fertility was analyzed with birth year- and education-adjusted logistic regression; association with mortality was
analyzed with age at baseline and education-adjusted Cox proportional hazard model
MAF minor allele frequency, OR odds ratio, HR hazard ratio, CI confidence interval
*p<0.05; **p<0.005
620 AGE (2011) 33:615–622(Rendina et al. 2010), and ovarian cancer (Yang et al.
2006). In this study, however, genetic variants in
FSHR gene influenced only fertility and not mortality,
suggesting that the effect of FSHR gene variants on
the other phenotypes is not fatal.
In exploring the relationship between fertility and
lifespan, we selected candidate genes that have been
shown to be involved in fertility. Another approach
would be to select genes that have been associated
with lifespan and assess their influence on fertility.
This approach was recently applied in a study
analyzing the influence of ACE, PON1, PPARG, and
APOE genes on fertility in 151 healthy unrelated
subjects in post-reproductive age (Corbo et al. 2008).
It was found that APOE*2 allele results in a trade-off
with fertility whereas the PPARG Pro/Ala genotype
contributes to beneficial effects both in early and in
late life in a gender-specific way. These results
warrant further research in analyzing candidate
longevity genes in relation to fertility.
A strength of the current study is the large study
population with a long follow-up time for mortality.
In addition, the availability of genome-wide genetic
data enabled us to investigate all to date known
common genetic variants in the selected candidate
genes. Another strength includes the fact that a
contemporary population was analyzed, which is less
selected than those used in historical studies (Hurt et
al. 2006). Furthermore, in contemporary populations,
data on birth and death dates and on the number of
children are likely to be more accurate than for
historical populations. On the other hand, the use of a
contemporary population poses also a problem due to
the use of birth control. Therefore, the reported
fertility would not entirely reflect natural fertility.
However, participants of this population were fertile
before the use of oral contraceptives became wide-
spread. In addition, we were able to adjust for the year
of birth, which should account for the differences in
fertility patterns over the years. A more likely source
of bias would be the self-reported age at menarche
and at menopause since older women may not
accurately recall these ages.
In conclusion, in this study, we observed that
women who bear fewer children are predicted to live
longer than those who bear none or many children. In
addition, we identified a number of SNPs that
associate with fertility. Despite that, none of the
identified SNPs associated with mortality. In this
study, we selected candidate genes based on their
direct role in HPO axis, folliculogenesis, and implan-
tation. It might be that genes influencing fertility
indirectly, either through lipid or glucose metabolism,
innate immunity, nutrition, or stress, are more likely
candidates to affect human lifespan.
Acknowledgements This study was supported by the
Netherlands Organization of Scientific Research (grant no
175.010.2005.011); the Netherlands Genomics Initiative
(NGI)/Netherlands Organization for Scientific Research
(NWO); Netherlands Consortium for Healthy Ageing (grant
no 050-060-810); the Erasmus Medical Center, and Erasmus
University in Rotterdam; the Netherlands Organization for
Health Research and Development; the Netherlands Research
Institute for Diseases in the Elderly; the Dutch Ministry of
Education, Culture and Science, and the Ministry for Health,
Welfare and Sports; the European Commission; and the
Municipality of Rotterdam, the Netherlands. H.T was supported
by Netherlands Organisation for Scientific Research (grant no
VIDI 017-106-370) and S.A. by Karolinska Institutet and
Enterprise Estonia (grant no EU30200). The funders had no
role in the study design or data collection and analysis. We
would like to thank everyone involved in the data collection
process of the Rotterdam study and the inhabitants of
Ommoord for their time and effort.
Competing interests The authors declare that there are no
competing interests associated with this study.
Open Access This article is distributed under the terms of the
Creative Commons Attribution Noncommercial License which
permits any noncommercial use, distribution, and reproduction
in any medium, provided the original author(s) and source are
credited.
References
Borgerhoff Mulder M (1989) Menarche, menopause and repro-
duction in the Kipsigis of Kenya. J Biosoc Sci 21:179–192
BrombergerJT,MatthewsKA,KullerLH,WingRR,MeilahnEN,
Plantinga P (1997) Prospective study of the determinants of
age at menopause. Am J Epidemiol 145:124–133
Buhmann B, Rainwater L, Schmaus G, Smeeding T (1988)
Equivalence scales well-being, inequality and poverty:
sensitivity estimates across ten countries using the
Luxembourg Income Study (LIS) data base. Rev Income
Wealth 34:115–142
Corbo RM, Ulizzi L, Piombo L, Scacchi R (2008) Study on a
possible effect of four longevity candidate genes (ACE,
PON1, PPAR-gamma, and APOE) on human fertility.
Biogerontology 9:317–323
Doblhammer G (2000) Reproductive history and mortality later
in life: a comparative study of England and Wales and
Austria. Popul Stud Camb 54:169–176
AGE (2011) 33:615–622 621Helle S, Lummaa V, Jokela J (2004) Accelerated immunose-
nescence in preindustrial twin mothers. Proc Natl Acad Sci
USA 101:12391–12396
Helm P, Munster K, Schmidt L (1995) Recalled menarche in
relation to infertility and adult weight and height. Acta
Obstet Gynecol Scand 74:718–722
Hofman A, Breteler MM, van Duijn CM, Janssen HL, Krestin
GP, Kuipers EJ, Stricker BH, Tiemeier H, Uitterlinden
AG, Vingerling JR, Witteman JC (2009) The Rotterdam
Study: 2010 objectives and design update. Eur J Epidemiol
24:553–572
Hu FB, Grodstein F, Hennekens CH, Colditz GA, Johnson M,
Manson JE, Rosner B, Stampfer MJ (1999) Age at natural
menopause and risk of cardiovascular disease. Arch Intern
Med 159:1061–1066
HurtLS,RonsmansC,ThomasSL(2006) Theeffectofnumber of
births on women’s mortality: systematic review of the
evidence for women who have completed their childbearing.
Popul Stud Camb 60:55–71
Kirkwood TB, Rose MR (1991) Evolution of senescence: late
survival sacrificed for reproduction. Philos Trans R Soc
Lond B Biol Sci 332:15–24
Kirkwood TBL (1977) Evolution of aging. Nature 270:301–304
Korpelainen H (2000) Fitness, reproduction and longevity
among European aristocratic and rural Finnish families in
the 1700s and 1800s. Proc Biol Sci 267:1765–1770
Kosova G, Abney M, Ober C (2010) Colloquium papers:
heritability of reproductive fitnesstraitsin a humanpopulation.
Proc Natl Acad Sci USA 107 Suppl 1:1772–1778
Lawlor DA, Emberson JR, Ebrahim S, Whincup PH, Wannamethee
SG, Walker M, Smith GD, British Women’s Heart and Health
Study, British Regional Heart Study (2003) Is the association
between parity and coronary heart disease due to biological
effects of pregnancy or adverse lifestyle risk factors associated
with child-rearing? Findings from the British Women’s Heart
and Health Study and the British Regional Heart Study.
Circulation 107:1260–1264
Le Bourg E (2007) Does reproduction decrease longevity in
human beings? Ageing Res Rev 6:141–149
Lycett JE, Dunbar RI, Voland E (2000) Longevity and the costs
of reproduction in a historical human population. Proc
Biol Sci 267:31–35
Martin U, Davies C, Hayavi S, Hartland A, Dunne F (1999) Is
normal pregnancy atherogenic? Clin Sci Lond 96:421–425
McArdle PF, Pollin TI, O’Connell JR, Sorkin JD, Agarwala R,
Schaffer AA, Streeten EA, King TM, Shuldiner AR,
Mitchell BD (2006) Does having children extend life
span? A genealogical study of parity and longevity in the
Amish. J Gerontol Biol Sci Med Sci 61:190–195
Muller HG, Chiou JM, Carey JR, Wang JL (2002) Fertility and
life span: late children enhance female longevity. J
Gerontol Biol Sci Med Sci 57:B202–B206
Nagirnaja L, Rull K, Uuskula L, Hallast P, Grigorova M, Laan
M (2010) Genomics and genetics of gonadotropin beta-
subunit genes: unique FSHB and duplicated LHB/CGB
loci. Mol Cell Endocrinol 329(1–2):4–16
Nakayama T, Kuroi N, Sano M, Tabara Y, Katsuya T, Ogihara
T, Makita Y, Hata A, Yamada M, Takahashi N, Hirawa N,
Umemura S, Miki T, Soma M (2006) Mutation of the
follicle-stimulating hormone receptor gene 5’-untranslated
region associated with female hypertension. Hypertension
48:512–518
Parazzini F, Negri E, La Vecchia C (1992) Reproductive and
general lifestyle determinants of age at menopause.
Maturitas 15:141–149
Penn DJ, Smith KR (2007) Differential fitness costs of reproduction
between the sexes. Proc Natl Acad Sci USA 104:553–558
Pettay JE, Kruuk LE, Jokela J, Lummaa V (2005) Heritability and
geneticconstraintsoflife-historytraitevolutioninpreindustrial
humans. Proc Natl Acad Sci USA 102:2838–2843
Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender
D, Maller J, Sklar P, de Bakker PI, Daly MJ, Sham PC (2007)
PLINK:atoolsetforwhole-genomeassociationandpopulation-
based linkage analyses. Am J Hum Genet 81:559–575
Qureshi AI, Giles WH, Croft JB, Stern BJ (1997) Number of
pregnancies and risk for stroke and stroke subtypes. Arch
Neurol 54:203–206
RendinaD,GianfrancescoF,DeFilippoG,MerlottiD,EspositoT,
Mingione A, Nuti R, Strazzullo P, Mossetti G, Gennari L
(2010) FSHR gene polymorphisms influence bone mineral
density and bone turnover in postmenopausal women. Eur J
Endocrinol 163:165–172
Rose M, Charlesworth B (1980) A test of evolutionary theories
of senescence. Nature 287:141–142
Sandler DP, Wilcox AJ, Horney LF (1984) Age at menarche and
subsequent reproductive events. AmJ Epidemiol119:765–774
Sattar N, Greer IA (2002) Pregnancy complications and
maternal cardiovascular risk: opportunities for intervention
and screening? BMJ 325:157–160
Sowers MR, La Pietra MT (1995) Menopause: its epidemiology
and potential association with chronic diseases. Epidemiol
Rev 17:287–302
Stanford JL, Hartge P, Brinton LA, Hoover RN, Brookmeyer R
(1987) Factors influencing the age at natural menopause. J
Chronic Dis 40:995–1002
Stearns SC, Partridge L (2001) The genetics of aging in Drosophila.
In: Masoro EJ, Austad SN (eds) Handbook of the biology of
aging, 5th edn. Academic Press, Orlando, pp 345–360
Westendorp RG, Kirkwood TB (1998) Human longevity at the
cost of reproductive success. Nature 396:743–746
Whelan EA, Sandler DP, McConnaughey DR, Weinberg CR
(1990) Menstrual and reproductive characteristics and age
at natural menopause. Am J Epidemiol 131:625–632
Williams GC (1957) Pleiotropy, natural selection, and the
evolution of senescence. Evolution 11:398–411
Winkvist A, Rasmussen KM, Habicht JP (1992) A new
definition of maternal depletion syndrome. Am J Public
Health 82:691–694
YangCQ,ChanKY,NganHY,KhooUS,ChiuPM,ChanQK,Xue
WC, Cheung AN (2006) Single nucleotide polymorphisms of
follicle-stimulating hormone receptor are associated with
ovarian cancer susceptibility. Carcinogenesis 27:1502–1506
622 AGE (2011) 33:615–622